Intrinsic Therapeutics Stock
Develops therapies to treat disc herniations in the spine for discectomy patients
Sign up today and learn more about Intrinsic Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Intrinsic Therapeutics Stock
Intrinsic Therapeutics is a medical device company that develops therapies for treating disc herniations in the spine for discectomy patients. It offers Barricaid anular prosthesis that allows the direct reconstruction of weakened and ruptured annulus and soft tissues of the spine. The company also offers spinal implants to treat the causes of sciatica and low back pain. It serves surgeons and patients. The company was formerly known as Intrinsic Orthopedics and changed its name to Intrinsic Therapeutics in January 2003. Intrinsic Therapeutics was founded in 2000 and is based in Woburn, Massachusetts.
Vice President, Global Sales
Founder & Executive Director
Vice President, Global Marketing
President and CEO
Chief Operating Officer